Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial (vol 142, pg 441, 2020)-MedSci.cn

Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial (vol 142, pg 441, 2020)

Gargiulo, G; Esposito, G; Avvedimento, M; Nagler, M; Minuz, P; Campo, G; Gragnano, F; Manavifar, N; Piccolo, R; Tebaldi, M; Cirillo, P; Hunziker, L; Vranckx, P; Leonardi, S; Heg, D; Windecker, S; Valgimigli, M

CIRCULATION, 2020; 142 (5): E71

科室
- - 订阅+
  - 更多科室
工具
服务

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial (vol 142, pg 441, 2020)

科室

工具

服务